Amalgamated Bank Gossamer Bio, Inc. Transaction History
Amalgamated Bank
- $13.6 Billion
- Q3 2025
A detailed history of Amalgamated Bank transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 6,486 shares of GOSS stock, worth $17,577. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,486
Previous 6,486
-0.0%
Holding current value
$17,577
Previous $7,000
142.86%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding GOSS
# of Institutions
167Shares Held
157MCall Options Held
7.83MPut Options Held
179K-
Nea Management Company, LLC Timonium, MD18.1MShares$49 Million2.97% of portfolio
-
Octagon Capital Advisors LP New York, NY17.1MShares$46.2 Million14.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$32.5 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$21.8 Million9.24% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA6.13MShares$16.6 Million6.11% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $255M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...